Josh Rappaport | Investor Relations |
John Leonard | Chief Executive Officer |
David Lebwohl | Chief Medical Officer |
Laura Sepp-Lorenzino | Chief Scientist Officer |
Glenn Goddard | Chief Financial Officer |
Maury Raycroft | Jefferies |
Rick Bienkowski | SVB Leerink |
Timur Ivannikov | Raymond James |
Joon Lee | Truist Securities |
Yanan Zhu | Wells Fargo |
Tashdid Hasan | ROTH Capital Partners |
Good morning. My name is Andrew and I will be your conference operator today and welcome to the Intellia Therapeutics Fourth Quarter 2020 Earnings Conference Call. [Operator Instructions] At this time, I would like to turn it over to Josh Rappaport, Managing Director at Stern Investor Relations. Please go ahead.
Thank you, operator.